Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Preparation and use of 7a-heterocycle substituted-6,6-difluoro bicyclic himbacine derivatives as PAR-1 receptor antagonists

Preparation and use of 7a-heterocycle substituted-6,6-difluoro bicyclic himbacine derivatives as PAR-1 receptor antagonists

US Patent 10322140 · Granted Jun 18, 2019

Estimated economic value: $129,517,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Carbamate and urea compounds as multikinase inhibitors2022
Cyclic compounds as immunomodulating agents2021
Macrocyclic compounds as TRK kinase inhibitors and uses thereof2021
Insulin dimer-incretin conjugates2021
Methods for using triazolo-pyrazinyl soluble guanylate cyclase activators in fib2021
Methods for using triazolo-pyrazinyl soluble guanylate cyclase activators in fib2021
Substituted quinolizine derivatives useful as HIV integrase inhibitors2020
Fused pyrazine derivatives useful as soluble guanylate cyclase stimulators2020
Compounds that are ERK inhibitors2020
Piperidine or piperazine linked imidazole and triazole derivatives and methods o2020
Imidazo-pyrazinyl derivatives useful as soluble guanylate cyclase activators2019
Compounds that are ERK inhibitors2018